HONG KONG -- (Marketwire) -- 02/10/12 -- Today, www.EquityLeader.com introduced research coverage of Seattle Genetics, Inc. (NASDAQ: SGEN) and Yandex NV (NASDAQ: YNDX). Full research reports are available to readers at: www.EquityLeader.com/index.php'sm1=SGEN&sm2=YNDX.
Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.
Equity Leader has decided to cover Seattle Genetics, Inc. for its current position within the healthcare industry. Seattle Genetics, Inc. (Seattle Genetics) is a clinical stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for cancer and autoimmune diseases. A copy of this report detailing Seattle Genetics, Inc. (NASDAQ: SGEN) is available at: www.EquityLeader.com/index.php'sm1=SGEN.
Equity Leader is also taking note of Yandex NV for its changing role within the technology industry. Yandex NV is a provider of internet services, headquartered in the Russian Federation. The Company operates a search engine, yandex.ru. In addition to the search engine which is also offered in Ukraine, Belarus and Kazakhstan, Yandex offers specialized search, personalized and location-based services, including Yandex.News, Yandex.Market, Yandex.Mail and Yandex. To download free research on Yandex NV (NASDAQ: YNDX) investors may visit: www.EquityLeader.com/index.php'sm2=YNDX.
About Equity Leader
Whether you are a first time investor or seasoned market professional, Equity Leader provides the resources necessary to simplify your research process. Our focus has always been to empower investors with the information they need to make their own investment decisions.
Contact:
Michael Westbrook
Email Contact
www.EquityLeader.com
